nodes	percent_of_prediction	percent_of_DWPC	metapath
Pilocarpine—CYP2A6—Methoxsalen—hematologic cancer	0.0739	0.124	CbGbCtD
Pilocarpine—CYP2A6—Ifosfamide—hematologic cancer	0.0539	0.0907	CbGbCtD
Pilocarpine—CYP2E1—Thalidomide—hematologic cancer	0.0404	0.068	CbGbCtD
Pilocarpine—CYP2A6—Prednisolone—hematologic cancer	0.0359	0.0604	CbGbCtD
Pilocarpine—CYP2E1—Dacarbazine—hematologic cancer	0.0347	0.0584	CbGbCtD
Pilocarpine—CYP2E1—Mitoxantrone—hematologic cancer	0.0269	0.0453	CbGbCtD
Pilocarpine—CYP3A4—Bexarotene—hematologic cancer	0.0229	0.0386	CbGbCtD
Pilocarpine—CYP3A4—Lomustine—hematologic cancer	0.0213	0.0359	CbGbCtD
Pilocarpine—CYP3A4—Busulfan—hematologic cancer	0.0213	0.0359	CbGbCtD
Pilocarpine—CYP2A6—Dexamethasone—hematologic cancer	0.0212	0.0356	CbGbCtD
Pilocarpine—CYP3A4—Thiotepa—hematologic cancer	0.019	0.032	CbGbCtD
Pilocarpine—CYP2E1—Etoposide—hematologic cancer	0.017	0.0286	CbGbCtD
Pilocarpine—CYP3A4—Methoxsalen—hematologic cancer	0.0148	0.0248	CbGbCtD
Pilocarpine—CYP3A4—Bortezomib—hematologic cancer	0.014	0.0236	CbGbCtD
Pilocarpine—CYP2E1—Dexamethasone—hematologic cancer	0.014	0.0235	CbGbCtD
Pilocarpine—CYP3A4—Daunorubicin—hematologic cancer	0.0134	0.0226	CbGbCtD
Pilocarpine—CYP3A4—Cytarabine—hematologic cancer	0.0119	0.0199	CbGbCtD
Pilocarpine—CYP3A4—Teniposide—hematologic cancer	0.0117	0.0196	CbGbCtD
Pilocarpine—CYP3A4—Ifosfamide—hematologic cancer	0.0108	0.0181	CbGbCtD
Pilocarpine—CYP3A4—Imatinib—hematologic cancer	0.0103	0.0173	CbGbCtD
Pilocarpine—CYP3A4—Ruxolitinib—hematologic cancer	0.00969	0.0163	CbGbCtD
Pilocarpine—CYP3A4—Nilotinib—hematologic cancer	0.00935	0.0157	CbGbCtD
Pilocarpine—CYP3A4—Vinorelbine—hematologic cancer	0.00928	0.0156	CbGbCtD
Pilocarpine—CYP3A4—Triamcinolone—hematologic cancer	0.00848	0.0143	CbGbCtD
Pilocarpine—CYP3A4—Dasatinib—hematologic cancer	0.00827	0.0139	CbGbCtD
Pilocarpine—CYP3A4—Mitoxantrone—hematologic cancer	0.00817	0.0137	CbGbCtD
Pilocarpine—CYP3A4—Betamethasone—hematologic cancer	0.00728	0.0122	CbGbCtD
Pilocarpine—CYP3A4—Prednisolone—hematologic cancer	0.00718	0.0121	CbGbCtD
Pilocarpine—CYP3A4—Prednisone—hematologic cancer	0.00678	0.0114	CbGbCtD
Pilocarpine—CYP3A4—Irinotecan—hematologic cancer	0.00643	0.0108	CbGbCtD
Pilocarpine—CYP3A4—Vinblastine—hematologic cancer	0.00572	0.00962	CbGbCtD
Pilocarpine—CYP3A4—Vincristine—hematologic cancer	0.00562	0.00945	CbGbCtD
Pilocarpine—CYP3A4—Etoposide—hematologic cancer	0.00515	0.00866	CbGbCtD
Pilocarpine—CYP3A4—Dexamethasone—hematologic cancer	0.00423	0.00712	CbGbCtD
Pilocarpine—CYP3A4—Doxorubicin—hematologic cancer	0.00351	0.00591	CbGbCtD
Pilocarpine—Flushing—Epirubicin—hematologic cancer	3.44e-05	9.63e-05	CcSEcCtD
Pilocarpine—Rhinitis—Doxorubicin—hematologic cancer	3.43e-05	9.62e-05	CcSEcCtD
Pilocarpine—Hepatitis—Doxorubicin—hematologic cancer	3.43e-05	9.6e-05	CcSEcCtD
Pilocarpine—Hypersensitivity—Prednisolone—hematologic cancer	3.41e-05	9.56e-05	CcSEcCtD
Pilocarpine—Hypoaesthesia—Doxorubicin—hematologic cancer	3.41e-05	9.55e-05	CcSEcCtD
Pilocarpine—Pharyngitis—Doxorubicin—hematologic cancer	3.4e-05	9.53e-05	CcSEcCtD
Pilocarpine—Dyspepsia—Betamethasone—hematologic cancer	3.4e-05	9.53e-05	CcSEcCtD
Pilocarpine—Dyspepsia—Dexamethasone—hematologic cancer	3.4e-05	9.53e-05	CcSEcCtD
Pilocarpine—Oedema peripheral—Doxorubicin—hematologic cancer	3.37e-05	9.46e-05	CcSEcCtD
Pilocarpine—Dysgeusia—Methotrexate—hematologic cancer	3.37e-05	9.45e-05	CcSEcCtD
Pilocarpine—Asthenia—Etoposide—hematologic cancer	3.37e-05	9.44e-05	CcSEcCtD
Pilocarpine—Body temperature increased—Triamcinolone—hematologic cancer	3.36e-05	9.43e-05	CcSEcCtD
Pilocarpine—Oedema—Prednisone—hematologic cancer	3.36e-05	9.43e-05	CcSEcCtD
Pilocarpine—Decreased appetite—Dexamethasone—hematologic cancer	3.36e-05	9.41e-05	CcSEcCtD
Pilocarpine—Decreased appetite—Betamethasone—hematologic cancer	3.36e-05	9.41e-05	CcSEcCtD
Pilocarpine—Nausea—Irinotecan—hematologic cancer	3.35e-05	9.39e-05	CcSEcCtD
Pilocarpine—Nausea—Mitoxantrone—hematologic cancer	3.35e-05	9.39e-05	CcSEcCtD
Pilocarpine—Infection—Prednisone—hematologic cancer	3.34e-05	9.36e-05	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.33e-05	9.34e-05	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.33e-05	9.34e-05	CcSEcCtD
Pilocarpine—Back pain—Methotrexate—hematologic cancer	3.33e-05	9.34e-05	CcSEcCtD
Pilocarpine—Chills—Epirubicin—hematologic cancer	3.32e-05	9.31e-05	CcSEcCtD
Pilocarpine—Pruritus—Etoposide—hematologic cancer	3.32e-05	9.3e-05	CcSEcCtD
Pilocarpine—Shock—Prednisone—hematologic cancer	3.31e-05	9.27e-05	CcSEcCtD
Pilocarpine—Arrhythmia—Epirubicin—hematologic cancer	3.31e-05	9.27e-05	CcSEcCtD
Pilocarpine—Pain—Dexamethasone—hematologic cancer	3.3e-05	9.25e-05	CcSEcCtD
Pilocarpine—Pain—Betamethasone—hematologic cancer	3.3e-05	9.25e-05	CcSEcCtD
Pilocarpine—Visual impairment—Doxorubicin—hematologic cancer	3.3e-05	9.25e-05	CcSEcCtD
Pilocarpine—Tachycardia—Prednisone—hematologic cancer	3.28e-05	9.2e-05	CcSEcCtD
Pilocarpine—Alopecia—Epirubicin—hematologic cancer	3.27e-05	9.17e-05	CcSEcCtD
Pilocarpine—Nausea—Gemcitabine—hematologic cancer	3.26e-05	9.15e-05	CcSEcCtD
Pilocarpine—Vomiting—Cisplatin—hematologic cancer	3.26e-05	9.13e-05	CcSEcCtD
Pilocarpine—Hyperhidrosis—Prednisone—hematologic cancer	3.25e-05	9.11e-05	CcSEcCtD
Pilocarpine—Vision blurred—Methotrexate—hematologic cancer	3.25e-05	9.1e-05	CcSEcCtD
Pilocarpine—Rash—Cisplatin—hematologic cancer	3.23e-05	9.05e-05	CcSEcCtD
Pilocarpine—Dermatitis—Cisplatin—hematologic cancer	3.23e-05	9.04e-05	CcSEcCtD
Pilocarpine—Diarrhoea—Etoposide—hematologic cancer	3.21e-05	9e-05	CcSEcCtD
Pilocarpine—Anorexia—Prednisone—hematologic cancer	3.21e-05	8.98e-05	CcSEcCtD
Pilocarpine—Eye disorder—Doxorubicin—hematologic cancer	3.2e-05	8.97e-05	CcSEcCtD
Pilocarpine—Tinnitus—Doxorubicin—hematologic cancer	3.19e-05	8.95e-05	CcSEcCtD
Pilocarpine—Feeling abnormal—Betamethasone—hematologic cancer	3.18e-05	8.92e-05	CcSEcCtD
Pilocarpine—Feeling abnormal—Dexamethasone—hematologic cancer	3.18e-05	8.92e-05	CcSEcCtD
Pilocarpine—Flushing—Doxorubicin—hematologic cancer	3.18e-05	8.91e-05	CcSEcCtD
Pilocarpine—Flatulence—Epirubicin—hematologic cancer	3.18e-05	8.9e-05	CcSEcCtD
Pilocarpine—Tension—Epirubicin—hematologic cancer	3.16e-05	8.86e-05	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.16e-05	8.85e-05	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Betamethasone—hematologic cancer	3.16e-05	8.85e-05	CcSEcCtD
Pilocarpine—Dysgeusia—Epirubicin—hematologic cancer	3.16e-05	8.84e-05	CcSEcCtD
Pilocarpine—Hypersensitivity—Triamcinolone—hematologic cancer	3.14e-05	8.79e-05	CcSEcCtD
Pilocarpine—Nervousness—Epirubicin—hematologic cancer	3.13e-05	8.77e-05	CcSEcCtD
Pilocarpine—Back pain—Epirubicin—hematologic cancer	3.12e-05	8.74e-05	CcSEcCtD
Pilocarpine—Dizziness—Etoposide—hematologic cancer	3.1e-05	8.7e-05	CcSEcCtD
Pilocarpine—Muscle spasms—Epirubicin—hematologic cancer	3.1e-05	8.68e-05	CcSEcCtD
Pilocarpine—Leukopenia—Methotrexate—hematologic cancer	3.08e-05	8.64e-05	CcSEcCtD
Pilocarpine—Chills—Doxorubicin—hematologic cancer	3.07e-05	8.61e-05	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.06e-05	8.59e-05	CcSEcCtD
Pilocarpine—Dizziness—Prednisolone—hematologic cancer	3.06e-05	8.58e-05	CcSEcCtD
Pilocarpine—Arrhythmia—Doxorubicin—hematologic cancer	3.06e-05	8.58e-05	CcSEcCtD
Pilocarpine—Asthenia—Triamcinolone—hematologic cancer	3.05e-05	8.56e-05	CcSEcCtD
Pilocarpine—Abdominal pain—Dexamethasone—hematologic cancer	3.05e-05	8.56e-05	CcSEcCtD
Pilocarpine—Body temperature increased—Dexamethasone—hematologic cancer	3.05e-05	8.56e-05	CcSEcCtD
Pilocarpine—Body temperature increased—Betamethasone—hematologic cancer	3.05e-05	8.56e-05	CcSEcCtD
Pilocarpine—Abdominal pain—Betamethasone—hematologic cancer	3.05e-05	8.56e-05	CcSEcCtD
Pilocarpine—Nausea—Cisplatin—hematologic cancer	3.04e-05	8.53e-05	CcSEcCtD
Pilocarpine—Insomnia—Prednisone—hematologic cancer	3.04e-05	8.52e-05	CcSEcCtD
Pilocarpine—Vision blurred—Epirubicin—hematologic cancer	3.04e-05	8.51e-05	CcSEcCtD
Pilocarpine—Alopecia—Doxorubicin—hematologic cancer	3.03e-05	8.48e-05	CcSEcCtD
Pilocarpine—Paraesthesia—Prednisone—hematologic cancer	3.02e-05	8.46e-05	CcSEcCtD
Pilocarpine—Pruritus—Triamcinolone—hematologic cancer	3.01e-05	8.44e-05	CcSEcCtD
Pilocarpine—Cough—Methotrexate—hematologic cancer	3.01e-05	8.42e-05	CcSEcCtD
Pilocarpine—Vomiting—Etoposide—hematologic cancer	2.98e-05	8.36e-05	CcSEcCtD
Pilocarpine—Agitation—Epirubicin—hematologic cancer	2.96e-05	8.3e-05	CcSEcCtD
Pilocarpine—Dyspepsia—Prednisone—hematologic cancer	2.96e-05	8.3e-05	CcSEcCtD
Pilocarpine—Rash—Etoposide—hematologic cancer	2.96e-05	8.29e-05	CcSEcCtD
Pilocarpine—Dermatitis—Etoposide—hematologic cancer	2.96e-05	8.28e-05	CcSEcCtD
Pilocarpine—Headache—Etoposide—hematologic cancer	2.94e-05	8.24e-05	CcSEcCtD
Pilocarpine—Flatulence—Doxorubicin—hematologic cancer	2.94e-05	8.24e-05	CcSEcCtD
Pilocarpine—Chest pain—Methotrexate—hematologic cancer	2.93e-05	8.22e-05	CcSEcCtD
Pilocarpine—Myalgia—Methotrexate—hematologic cancer	2.93e-05	8.22e-05	CcSEcCtD
Pilocarpine—Arthralgia—Methotrexate—hematologic cancer	2.93e-05	8.22e-05	CcSEcCtD
Pilocarpine—Tension—Doxorubicin—hematologic cancer	2.93e-05	8.2e-05	CcSEcCtD
Pilocarpine—Decreased appetite—Prednisone—hematologic cancer	2.92e-05	8.19e-05	CcSEcCtD
Pilocarpine—Dysgeusia—Doxorubicin—hematologic cancer	2.92e-05	8.18e-05	CcSEcCtD
Pilocarpine—Rash—Prednisolone—hematologic cancer	2.92e-05	8.18e-05	CcSEcCtD
Pilocarpine—Dermatitis—Prednisolone—hematologic cancer	2.92e-05	8.17e-05	CcSEcCtD
Pilocarpine—Headache—Prednisolone—hematologic cancer	2.9e-05	8.13e-05	CcSEcCtD
Pilocarpine—Discomfort—Methotrexate—hematologic cancer	2.9e-05	8.12e-05	CcSEcCtD
Pilocarpine—Nervousness—Doxorubicin—hematologic cancer	2.9e-05	8.12e-05	CcSEcCtD
Pilocarpine—Syncope—Epirubicin—hematologic cancer	2.89e-05	8.1e-05	CcSEcCtD
Pilocarpine—Leukopenia—Epirubicin—hematologic cancer	2.89e-05	8.08e-05	CcSEcCtD
Pilocarpine—Back pain—Doxorubicin—hematologic cancer	2.88e-05	8.08e-05	CcSEcCtD
Pilocarpine—Constipation—Prednisone—hematologic cancer	2.88e-05	8.06e-05	CcSEcCtD
Pilocarpine—Muscle spasms—Doxorubicin—hematologic cancer	2.87e-05	8.03e-05	CcSEcCtD
Pilocarpine—Palpitations—Epirubicin—hematologic cancer	2.85e-05	7.98e-05	CcSEcCtD
Pilocarpine—Confusional state—Methotrexate—hematologic cancer	2.83e-05	7.94e-05	CcSEcCtD
Pilocarpine—Loss of consciousness—Epirubicin—hematologic cancer	2.83e-05	7.94e-05	CcSEcCtD
Pilocarpine—Dizziness—Triamcinolone—hematologic cancer	2.81e-05	7.89e-05	CcSEcCtD
Pilocarpine—Cough—Epirubicin—hematologic cancer	2.81e-05	7.88e-05	CcSEcCtD
Pilocarpine—Vision blurred—Doxorubicin—hematologic cancer	2.81e-05	7.88e-05	CcSEcCtD
Pilocarpine—Infection—Methotrexate—hematologic cancer	2.79e-05	7.83e-05	CcSEcCtD
Pilocarpine—Nausea—Etoposide—hematologic cancer	2.79e-05	7.81e-05	CcSEcCtD
Pilocarpine—Hypertension—Epirubicin—hematologic cancer	2.78e-05	7.8e-05	CcSEcCtD
Pilocarpine—Feeling abnormal—Prednisone—hematologic cancer	2.77e-05	7.77e-05	CcSEcCtD
Pilocarpine—Asthenia—Betamethasone—hematologic cancer	2.77e-05	7.77e-05	CcSEcCtD
Pilocarpine—Asthenia—Dexamethasone—hematologic cancer	2.77e-05	7.77e-05	CcSEcCtD
Pilocarpine—Thrombocytopenia—Methotrexate—hematologic cancer	2.75e-05	7.71e-05	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Prednisone—hematologic cancer	2.75e-05	7.71e-05	CcSEcCtD
Pilocarpine—Nausea—Prednisolone—hematologic cancer	2.75e-05	7.7e-05	CcSEcCtD
Pilocarpine—Arthralgia—Epirubicin—hematologic cancer	2.74e-05	7.69e-05	CcSEcCtD
Pilocarpine—Myalgia—Epirubicin—hematologic cancer	2.74e-05	7.69e-05	CcSEcCtD
Pilocarpine—Chest pain—Epirubicin—hematologic cancer	2.74e-05	7.69e-05	CcSEcCtD
Pilocarpine—Agitation—Doxorubicin—hematologic cancer	2.74e-05	7.68e-05	CcSEcCtD
Pilocarpine—Anxiety—Epirubicin—hematologic cancer	2.73e-05	7.66e-05	CcSEcCtD
Pilocarpine—Pruritus—Betamethasone—hematologic cancer	2.73e-05	7.66e-05	CcSEcCtD
Pilocarpine—Pruritus—Dexamethasone—hematologic cancer	2.73e-05	7.66e-05	CcSEcCtD
Pilocarpine—Hyperhidrosis—Methotrexate—hematologic cancer	2.72e-05	7.61e-05	CcSEcCtD
Pilocarpine—Discomfort—Epirubicin—hematologic cancer	2.71e-05	7.6e-05	CcSEcCtD
Pilocarpine—Vomiting—Triamcinolone—hematologic cancer	2.71e-05	7.58e-05	CcSEcCtD
Pilocarpine—Rash—Triamcinolone—hematologic cancer	2.68e-05	7.52e-05	CcSEcCtD
Pilocarpine—Dermatitis—Triamcinolone—hematologic cancer	2.68e-05	7.51e-05	CcSEcCtD
Pilocarpine—Anorexia—Methotrexate—hematologic cancer	2.68e-05	7.51e-05	CcSEcCtD
Pilocarpine—Syncope—Doxorubicin—hematologic cancer	2.67e-05	7.49e-05	CcSEcCtD
Pilocarpine—Leukopenia—Doxorubicin—hematologic cancer	2.67e-05	7.48e-05	CcSEcCtD
Pilocarpine—Headache—Triamcinolone—hematologic cancer	2.67e-05	7.47e-05	CcSEcCtD
Pilocarpine—Abdominal pain—Prednisone—hematologic cancer	2.66e-05	7.45e-05	CcSEcCtD
Pilocarpine—Body temperature increased—Prednisone—hematologic cancer	2.66e-05	7.45e-05	CcSEcCtD
Pilocarpine—Confusional state—Epirubicin—hematologic cancer	2.65e-05	7.43e-05	CcSEcCtD
Pilocarpine—Diarrhoea—Betamethasone—hematologic cancer	2.64e-05	7.4e-05	CcSEcCtD
Pilocarpine—Diarrhoea—Dexamethasone—hematologic cancer	2.64e-05	7.4e-05	CcSEcCtD
Pilocarpine—Palpitations—Doxorubicin—hematologic cancer	2.64e-05	7.39e-05	CcSEcCtD
Pilocarpine—Oedema—Epirubicin—hematologic cancer	2.63e-05	7.37e-05	CcSEcCtD
Pilocarpine—Hypotension—Methotrexate—hematologic cancer	2.63e-05	7.36e-05	CcSEcCtD
Pilocarpine—Loss of consciousness—Doxorubicin—hematologic cancer	2.62e-05	7.35e-05	CcSEcCtD
Pilocarpine—Infection—Epirubicin—hematologic cancer	2.61e-05	7.32e-05	CcSEcCtD
Pilocarpine—Cough—Doxorubicin—hematologic cancer	2.6e-05	7.29e-05	CcSEcCtD
Pilocarpine—Shock—Epirubicin—hematologic cancer	2.59e-05	7.25e-05	CcSEcCtD
Pilocarpine—Thrombocytopenia—Epirubicin—hematologic cancer	2.58e-05	7.22e-05	CcSEcCtD
Pilocarpine—Hypertension—Doxorubicin—hematologic cancer	2.57e-05	7.22e-05	CcSEcCtD
Pilocarpine—Tachycardia—Epirubicin—hematologic cancer	2.57e-05	7.19e-05	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.56e-05	7.18e-05	CcSEcCtD
Pilocarpine—Dizziness—Dexamethasone—hematologic cancer	2.55e-05	7.16e-05	CcSEcCtD
Pilocarpine—Dizziness—Betamethasone—hematologic cancer	2.55e-05	7.16e-05	CcSEcCtD
Pilocarpine—Hyperhidrosis—Epirubicin—hematologic cancer	2.54e-05	7.13e-05	CcSEcCtD
Pilocarpine—Insomnia—Methotrexate—hematologic cancer	2.54e-05	7.12e-05	CcSEcCtD
Pilocarpine—Chest pain—Doxorubicin—hematologic cancer	2.54e-05	7.11e-05	CcSEcCtD
Pilocarpine—Myalgia—Doxorubicin—hematologic cancer	2.54e-05	7.11e-05	CcSEcCtD
Pilocarpine—Arthralgia—Doxorubicin—hematologic cancer	2.54e-05	7.11e-05	CcSEcCtD
Pilocarpine—Anxiety—Doxorubicin—hematologic cancer	2.53e-05	7.09e-05	CcSEcCtD
Pilocarpine—Nausea—Triamcinolone—hematologic cancer	2.53e-05	7.08e-05	CcSEcCtD
Pilocarpine—Paraesthesia—Methotrexate—hematologic cancer	2.52e-05	7.07e-05	CcSEcCtD
Pilocarpine—Discomfort—Doxorubicin—hematologic cancer	2.51e-05	7.03e-05	CcSEcCtD
Pilocarpine—Anorexia—Epirubicin—hematologic cancer	2.51e-05	7.03e-05	CcSEcCtD
Pilocarpine—Dyspnoea—Methotrexate—hematologic cancer	2.51e-05	7.02e-05	CcSEcCtD
Pilocarpine—Somnolence—Methotrexate—hematologic cancer	2.5e-05	7e-05	CcSEcCtD
Pilocarpine—Hypersensitivity—Prednisone—hematologic cancer	2.48e-05	6.94e-05	CcSEcCtD
Pilocarpine—Dyspepsia—Methotrexate—hematologic cancer	2.47e-05	6.93e-05	CcSEcCtD
Pilocarpine—Hypotension—Epirubicin—hematologic cancer	2.46e-05	6.89e-05	CcSEcCtD
Pilocarpine—Vomiting—Dexamethasone—hematologic cancer	2.46e-05	6.88e-05	CcSEcCtD
Pilocarpine—Vomiting—Betamethasone—hematologic cancer	2.46e-05	6.88e-05	CcSEcCtD
Pilocarpine—Confusional state—Doxorubicin—hematologic cancer	2.45e-05	6.88e-05	CcSEcCtD
Pilocarpine—Decreased appetite—Methotrexate—hematologic cancer	2.44e-05	6.85e-05	CcSEcCtD
Pilocarpine—Rash—Dexamethasone—hematologic cancer	2.44e-05	6.82e-05	CcSEcCtD
Pilocarpine—Rash—Betamethasone—hematologic cancer	2.44e-05	6.82e-05	CcSEcCtD
Pilocarpine—Oedema—Doxorubicin—hematologic cancer	2.43e-05	6.82e-05	CcSEcCtD
Pilocarpine—Dermatitis—Dexamethasone—hematologic cancer	2.43e-05	6.82e-05	CcSEcCtD
Pilocarpine—Dermatitis—Betamethasone—hematologic cancer	2.43e-05	6.82e-05	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.43e-05	6.8e-05	CcSEcCtD
Pilocarpine—Headache—Betamethasone—hematologic cancer	2.42e-05	6.78e-05	CcSEcCtD
Pilocarpine—Headache—Dexamethasone—hematologic cancer	2.42e-05	6.78e-05	CcSEcCtD
Pilocarpine—Infection—Doxorubicin—hematologic cancer	2.42e-05	6.78e-05	CcSEcCtD
Pilocarpine—Asthenia—Prednisone—hematologic cancer	2.41e-05	6.76e-05	CcSEcCtD
Pilocarpine—Pain—Methotrexate—hematologic cancer	2.4e-05	6.74e-05	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.4e-05	6.72e-05	CcSEcCtD
Pilocarpine—Shock—Doxorubicin—hematologic cancer	2.39e-05	6.71e-05	CcSEcCtD
Pilocarpine—Thrombocytopenia—Doxorubicin—hematologic cancer	2.38e-05	6.68e-05	CcSEcCtD
Pilocarpine—Pruritus—Prednisone—hematologic cancer	2.38e-05	6.67e-05	CcSEcCtD
Pilocarpine—Insomnia—Epirubicin—hematologic cancer	2.38e-05	6.67e-05	CcSEcCtD
Pilocarpine—Tachycardia—Doxorubicin—hematologic cancer	2.38e-05	6.66e-05	CcSEcCtD
Pilocarpine—Paraesthesia—Epirubicin—hematologic cancer	2.36e-05	6.62e-05	CcSEcCtD
Pilocarpine—Hyperhidrosis—Doxorubicin—hematologic cancer	2.35e-05	6.59e-05	CcSEcCtD
Pilocarpine—Dyspnoea—Epirubicin—hematologic cancer	2.35e-05	6.57e-05	CcSEcCtD
Pilocarpine—Somnolence—Epirubicin—hematologic cancer	2.34e-05	6.55e-05	CcSEcCtD
Pilocarpine—Anorexia—Doxorubicin—hematologic cancer	2.32e-05	6.5e-05	CcSEcCtD
Pilocarpine—Feeling abnormal—Methotrexate—hematologic cancer	2.32e-05	6.49e-05	CcSEcCtD
Pilocarpine—Dyspepsia—Epirubicin—hematologic cancer	2.32e-05	6.49e-05	CcSEcCtD
Pilocarpine—Diarrhoea—Prednisone—hematologic cancer	2.3e-05	6.45e-05	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Methotrexate—hematologic cancer	2.3e-05	6.44e-05	CcSEcCtD
Pilocarpine—Nausea—Betamethasone—hematologic cancer	2.29e-05	6.43e-05	CcSEcCtD
Pilocarpine—Nausea—Dexamethasone—hematologic cancer	2.29e-05	6.43e-05	CcSEcCtD
Pilocarpine—Decreased appetite—Epirubicin—hematologic cancer	2.29e-05	6.41e-05	CcSEcCtD
Pilocarpine—Hypotension—Doxorubicin—hematologic cancer	2.27e-05	6.37e-05	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.27e-05	6.36e-05	CcSEcCtD
Pilocarpine—Pain—Epirubicin—hematologic cancer	2.25e-05	6.3e-05	CcSEcCtD
Pilocarpine—Constipation—Epirubicin—hematologic cancer	2.25e-05	6.3e-05	CcSEcCtD
Pilocarpine—Dizziness—Prednisone—hematologic cancer	2.22e-05	6.23e-05	CcSEcCtD
Pilocarpine—Body temperature increased—Methotrexate—hematologic cancer	2.22e-05	6.23e-05	CcSEcCtD
Pilocarpine—Abdominal pain—Methotrexate—hematologic cancer	2.22e-05	6.23e-05	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.22e-05	6.21e-05	CcSEcCtD
Pilocarpine—Insomnia—Doxorubicin—hematologic cancer	2.2e-05	6.17e-05	CcSEcCtD
Pilocarpine—Paraesthesia—Doxorubicin—hematologic cancer	2.19e-05	6.12e-05	CcSEcCtD
Pilocarpine—Dyspnoea—Doxorubicin—hematologic cancer	2.17e-05	6.08e-05	CcSEcCtD
Pilocarpine—Feeling abnormal—Epirubicin—hematologic cancer	2.17e-05	6.07e-05	CcSEcCtD
Pilocarpine—Somnolence—Doxorubicin—hematologic cancer	2.16e-05	6.06e-05	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Epirubicin—hematologic cancer	2.15e-05	6.03e-05	CcSEcCtD
Pilocarpine—Dyspepsia—Doxorubicin—hematologic cancer	2.14e-05	6e-05	CcSEcCtD
Pilocarpine—Vomiting—Prednisone—hematologic cancer	2.14e-05	5.99e-05	CcSEcCtD
Pilocarpine—Rash—Prednisone—hematologic cancer	2.12e-05	5.94e-05	CcSEcCtD
Pilocarpine—Dermatitis—Prednisone—hematologic cancer	2.12e-05	5.94e-05	CcSEcCtD
Pilocarpine—Decreased appetite—Doxorubicin—hematologic cancer	2.12e-05	5.93e-05	CcSEcCtD
Pilocarpine—Headache—Prednisone—hematologic cancer	2.11e-05	5.9e-05	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.1e-05	5.89e-05	CcSEcCtD
Pilocarpine—Constipation—Doxorubicin—hematologic cancer	2.08e-05	5.83e-05	CcSEcCtD
Pilocarpine—Pain—Doxorubicin—hematologic cancer	2.08e-05	5.83e-05	CcSEcCtD
Pilocarpine—Abdominal pain—Epirubicin—hematologic cancer	2.08e-05	5.83e-05	CcSEcCtD
Pilocarpine—Body temperature increased—Epirubicin—hematologic cancer	2.08e-05	5.83e-05	CcSEcCtD
Pilocarpine—Hypersensitivity—Methotrexate—hematologic cancer	2.07e-05	5.8e-05	CcSEcCtD
Pilocarpine—Asthenia—Methotrexate—hematologic cancer	2.02e-05	5.65e-05	CcSEcCtD
Pilocarpine—Feeling abnormal—Doxorubicin—hematologic cancer	2.01e-05	5.62e-05	CcSEcCtD
Pilocarpine—Nausea—Prednisone—hematologic cancer	2e-05	5.6e-05	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.99e-05	5.58e-05	CcSEcCtD
Pilocarpine—Pruritus—Methotrexate—hematologic cancer	1.99e-05	5.57e-05	CcSEcCtD
Pilocarpine—Hypersensitivity—Epirubicin—hematologic cancer	1.94e-05	5.43e-05	CcSEcCtD
Pilocarpine—Abdominal pain—Doxorubicin—hematologic cancer	1.92e-05	5.39e-05	CcSEcCtD
Pilocarpine—Body temperature increased—Doxorubicin—hematologic cancer	1.92e-05	5.39e-05	CcSEcCtD
Pilocarpine—Diarrhoea—Methotrexate—hematologic cancer	1.92e-05	5.39e-05	CcSEcCtD
Pilocarpine—Asthenia—Epirubicin—hematologic cancer	1.89e-05	5.29e-05	CcSEcCtD
Pilocarpine—Pruritus—Epirubicin—hematologic cancer	1.86e-05	5.22e-05	CcSEcCtD
Pilocarpine—Dizziness—Methotrexate—hematologic cancer	1.86e-05	5.21e-05	CcSEcCtD
Pilocarpine—Diarrhoea—Epirubicin—hematologic cancer	1.8e-05	5.04e-05	CcSEcCtD
Pilocarpine—Hypersensitivity—Doxorubicin—hematologic cancer	1.79e-05	5.03e-05	CcSEcCtD
Pilocarpine—Vomiting—Methotrexate—hematologic cancer	1.79e-05	5.01e-05	CcSEcCtD
Pilocarpine—Rash—Methotrexate—hematologic cancer	1.77e-05	4.97e-05	CcSEcCtD
Pilocarpine—Dermatitis—Methotrexate—hematologic cancer	1.77e-05	4.96e-05	CcSEcCtD
Pilocarpine—Headache—Methotrexate—hematologic cancer	1.76e-05	4.93e-05	CcSEcCtD
Pilocarpine—Asthenia—Doxorubicin—hematologic cancer	1.75e-05	4.89e-05	CcSEcCtD
Pilocarpine—Dizziness—Epirubicin—hematologic cancer	1.74e-05	4.87e-05	CcSEcCtD
Pilocarpine—Pruritus—Doxorubicin—hematologic cancer	1.72e-05	4.83e-05	CcSEcCtD
Pilocarpine—Vomiting—Epirubicin—hematologic cancer	1.67e-05	4.69e-05	CcSEcCtD
Pilocarpine—Nausea—Methotrexate—hematologic cancer	1.67e-05	4.68e-05	CcSEcCtD
Pilocarpine—Diarrhoea—Doxorubicin—hematologic cancer	1.67e-05	4.67e-05	CcSEcCtD
Pilocarpine—Rash—Epirubicin—hematologic cancer	1.66e-05	4.65e-05	CcSEcCtD
Pilocarpine—Dermatitis—Epirubicin—hematologic cancer	1.66e-05	4.64e-05	CcSEcCtD
Pilocarpine—Headache—Epirubicin—hematologic cancer	1.65e-05	4.62e-05	CcSEcCtD
Pilocarpine—Dizziness—Doxorubicin—hematologic cancer	1.61e-05	4.51e-05	CcSEcCtD
Pilocarpine—Nausea—Epirubicin—hematologic cancer	1.56e-05	4.38e-05	CcSEcCtD
Pilocarpine—Vomiting—Doxorubicin—hematologic cancer	1.55e-05	4.34e-05	CcSEcCtD
Pilocarpine—Rash—Doxorubicin—hematologic cancer	1.53e-05	4.3e-05	CcSEcCtD
Pilocarpine—Dermatitis—Doxorubicin—hematologic cancer	1.53e-05	4.3e-05	CcSEcCtD
Pilocarpine—Headache—Doxorubicin—hematologic cancer	1.52e-05	4.27e-05	CcSEcCtD
Pilocarpine—Nausea—Doxorubicin—hematologic cancer	1.45e-05	4.05e-05	CcSEcCtD
Pilocarpine—CHRM2—Signaling Pathways—PDGFRA—hematologic cancer	6.61e-06	0.000135	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PIK3CG—hematologic cancer	6.6e-06	0.000135	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—TXN—hematologic cancer	6.59e-06	0.000135	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GSTO1—hematologic cancer	6.59e-06	0.000135	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ABCC3—hematologic cancer	6.59e-06	0.000135	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—JAK1—hematologic cancer	6.58e-06	0.000135	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PRKCG—hematologic cancer	6.58e-06	0.000135	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—SPHK1—hematologic cancer	6.45e-06	0.000132	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IL2RA—hematologic cancer	6.23e-06	0.000128	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IL2RA—hematologic cancer	6.21e-06	0.000127	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—MTHFR—hematologic cancer	6.2e-06	0.000127	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	6.2e-06	0.000127	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PIK3CG—hematologic cancer	6.19e-06	0.000127	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—IL2—hematologic cancer	6.18e-06	0.000127	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—IL2—hematologic cancer	6.16e-06	0.000126	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TERT—hematologic cancer	6.16e-06	0.000126	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IL2RA—hematologic cancer	6.15e-06	0.000126	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TERT—hematologic cancer	6.14e-06	0.000126	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—CREBBP—hematologic cancer	6.11e-06	0.000125	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—IL2—hematologic cancer	6.1e-06	0.000125	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TERT—hematologic cancer	6.08e-06	0.000125	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CRABP1—hematologic cancer	6.03e-06	0.000124	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	6.03e-06	0.000124	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PDGFB—hematologic cancer	6.01e-06	0.000123	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PDGFB—hematologic cancer	5.99e-06	0.000123	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PDGFB—hematologic cancer	5.93e-06	0.000122	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ALOX5—hematologic cancer	5.88e-06	0.00012	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TSC2—hematologic cancer	5.88e-06	0.00012	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TSC2—hematologic cancer	5.86e-06	0.00012	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TSC2—hematologic cancer	5.8e-06	0.000119	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PIK3CD—hematologic cancer	5.8e-06	0.000119	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—CREBBP—hematologic cancer	5.74e-06	0.000118	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—ALB—hematologic cancer	5.72e-06	0.000117	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—NUP98—hematologic cancer	5.69e-06	0.000117	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—FGFR3—hematologic cancer	5.65e-06	0.000116	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—FGFR3—hematologic cancer	5.63e-06	0.000116	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MAPK14—hematologic cancer	5.6e-06	0.000115	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—FGFR3—hematologic cancer	5.58e-06	0.000114	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MAPK14—hematologic cancer	5.58e-06	0.000114	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ADCY7—hematologic cancer	5.53e-06	0.000113	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—NCOA3—hematologic cancer	5.53e-06	0.000113	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MAPK14—hematologic cancer	5.52e-06	0.000113	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—ESR1—hematologic cancer	5.49e-06	0.000113	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—NUP214—hematologic cancer	5.49e-06	0.000112	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PIK3R1—hematologic cancer	5.47e-06	0.000112	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—ESR1—hematologic cancer	5.47e-06	0.000112	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PIK3CD—hematologic cancer	5.44e-06	0.000111	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—FN1—hematologic cancer	5.42e-06	0.000111	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—ESR1—hematologic cancer	5.42e-06	0.000111	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—FN1—hematologic cancer	5.4e-06	0.000111	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ABCG2—hematologic cancer	5.38e-06	0.00011	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—MTR—hematologic cancer	5.38e-06	0.00011	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—ALB—hematologic cancer	5.37e-06	0.00011	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—BAD—hematologic cancer	5.36e-06	0.00011	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—NFKBIA—hematologic cancer	5.36e-06	0.00011	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—FN1—hematologic cancer	5.35e-06	0.00011	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—BAD—hematologic cancer	5.34e-06	0.000109	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—NFKBIA—hematologic cancer	5.34e-06	0.000109	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—NOTCH1—hematologic cancer	5.31e-06	0.000109	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—NOTCH1—hematologic cancer	5.29e-06	0.000108	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—NFKBIA—hematologic cancer	5.29e-06	0.000108	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—BAD—hematologic cancer	5.29e-06	0.000108	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ENO2—hematologic cancer	5.27e-06	0.000108	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—NOTCH1—hematologic cancer	5.24e-06	0.000107	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PIK3CG—hematologic cancer	5.21e-06	0.000107	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CD80—hematologic cancer	5.2e-06	0.000107	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—KIT—hematologic cancer	5.19e-06	0.000106	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PIK3CG—hematologic cancer	5.19e-06	0.000106	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—NRAS—hematologic cancer	5.19e-06	0.000106	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CD80—hematologic cancer	5.18e-06	0.000106	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PIK3CG—hematologic cancer	5.17e-06	0.000106	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—KIT—hematologic cancer	5.17e-06	0.000106	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—NRAS—hematologic cancer	5.17e-06	0.000106	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PIK3R1—hematologic cancer	5.13e-06	0.000105	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CD80—hematologic cancer	5.13e-06	0.000105	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PIK3CG—hematologic cancer	5.12e-06	0.000105	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—KIT—hematologic cancer	5.12e-06	0.000105	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—NRAS—hematologic cancer	5.12e-06	0.000105	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GSTT1—hematologic cancer	5.11e-06	0.000105	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PTPN11—hematologic cancer	5.1e-06	0.000105	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PTPN11—hematologic cancer	5.08e-06	0.000104	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PIK3CB—hematologic cancer	5.05e-06	0.000104	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PTPN11—hematologic cancer	5.03e-06	0.000103	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—SDC1—hematologic cancer	5e-06	0.000102	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—MAPK3—hematologic cancer	4.97e-06	0.000102	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—MAPK3—hematologic cancer	4.95e-06	0.000102	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CREB1—hematologic cancer	4.94e-06	0.000101	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CREB1—hematologic cancer	4.92e-06	0.000101	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—MAPK3—hematologic cancer	4.91e-06	0.000101	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—BRAF—hematologic cancer	4.88e-06	0.0001	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CREB1—hematologic cancer	4.88e-06	0.0001	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—BRAF—hematologic cancer	4.86e-06	9.97e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CCL2—hematologic cancer	4.83e-06	9.91e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CREBBP—hematologic cancer	4.83e-06	9.91e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IL6R—hematologic cancer	4.82e-06	9.88e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CCL2—hematologic cancer	4.82e-06	9.88e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—BRAF—hematologic cancer	4.81e-06	9.87e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CREBBP—hematologic cancer	4.81e-06	9.86e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IL6R—hematologic cancer	4.8e-06	9.85e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CREBBP—hematologic cancer	4.8e-06	9.83e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CCL2—hematologic cancer	4.77e-06	9.78e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IL6R—hematologic cancer	4.76e-06	9.75e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CREBBP—hematologic cancer	4.75e-06	9.74e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PIK3CB—hematologic cancer	4.74e-06	9.72e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MAP2K1—hematologic cancer	4.59e-06	9.41e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PIK3CD—hematologic cancer	4.58e-06	9.39e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MAP2K1—hematologic cancer	4.58e-06	9.38e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PIK3CD—hematologic cancer	4.56e-06	9.35e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PIK3CD—hematologic cancer	4.55e-06	9.32e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MAP2K1—hematologic cancer	4.53e-06	9.29e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—ALB—hematologic cancer	4.52e-06	9.27e-05	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	4.52e-06	9.26e-05	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—PIK3CA—hematologic cancer	4.5e-06	9.23e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PIK3CD—hematologic cancer	4.5e-06	9.23e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—KRAS—hematologic cancer	4.47e-06	9.16e-05	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—PIK3CA—hematologic cancer	4.46e-06	9.14e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—KRAS—hematologic cancer	4.45e-06	9.13e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—KRAS—hematologic cancer	4.41e-06	9.04e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—FGF2—hematologic cancer	4.37e-06	8.95e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PTEN—hematologic cancer	4.37e-06	8.95e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—FGF2—hematologic cancer	4.35e-06	8.93e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PIK3R1—hematologic cancer	4.33e-06	8.87e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—FGF2—hematologic cancer	4.31e-06	8.84e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PIK3R1—hematologic cancer	4.31e-06	8.83e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PIK3R1—hematologic cancer	4.29e-06	8.8e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PIK3R1—hematologic cancer	4.25e-06	8.72e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CD44—hematologic cancer	4.25e-06	8.71e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—NQO1—hematologic cancer	4.25e-06	8.71e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—JAK2—hematologic cancer	4.19e-06	8.58e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—JAK2—hematologic cancer	4.17e-06	8.56e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—EP300—hematologic cancer	4.16e-06	8.54e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—JAK2—hematologic cancer	4.13e-06	8.47e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—PIK3CA—hematologic cancer	4.1e-06	8.41e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PTEN—hematologic cancer	4.1e-06	8.4e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—PIK3CA—hematologic cancer	4.09e-06	8.39e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MDM2—hematologic cancer	4.09e-06	8.38e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MDM2—hematologic cancer	4.07e-06	8.35e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—PIK3CA—hematologic cancer	4.05e-06	8.3e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MDM2—hematologic cancer	4.03e-06	8.27e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYCS—hematologic cancer	4.02e-06	8.24e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.99e-06	8.19e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PIK3CB—hematologic cancer	3.99e-06	8.19e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PIK3CB—hematologic cancer	3.98e-06	8.15e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MTOR—hematologic cancer	3.98e-06	8.15e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PIK3CB—hematologic cancer	3.96e-06	8.13e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MTOR—hematologic cancer	3.96e-06	8.13e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MTOR—hematologic cancer	3.92e-06	8.05e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PIK3CB—hematologic cancer	3.92e-06	8.05e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—EP300—hematologic cancer	3.91e-06	8.01e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—HRAS—hematologic cancer	3.8e-06	7.78e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—HRAS—hematologic cancer	3.78e-06	7.76e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—HRAS—hematologic cancer	3.75e-06	7.68e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CDKN1B—hematologic cancer	3.73e-06	7.65e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CDKN1B—hematologic cancer	3.72e-06	7.63e-05	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—AKT1—hematologic cancer	3.69e-06	7.57e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CDKN1B—hematologic cancer	3.68e-06	7.55e-05	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—AKT1—hematologic cancer	3.68e-06	7.54e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CASP3—hematologic cancer	3.66e-06	7.5e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IL2—hematologic cancer	3.65e-06	7.49e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CASP3—hematologic cancer	3.65e-06	7.47e-05	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—AKT1—hematologic cancer	3.64e-06	7.47e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IL2—hematologic cancer	3.64e-06	7.46e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—IL6—hematologic cancer	3.63e-06	7.45e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—IL6—hematologic cancer	3.62e-06	7.43e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CASP3—hematologic cancer	3.61e-06	7.4e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IL2—hematologic cancer	3.6e-06	7.39e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—IL6—hematologic cancer	3.59e-06	7.35e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CCND1—hematologic cancer	3.56e-06	7.3e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—JUN—hematologic cancer	3.55e-06	7.28e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CCND1—hematologic cancer	3.55e-06	7.27e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.54e-06	7.27e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—JUN—hematologic cancer	3.54e-06	7.26e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CCND1—hematologic cancer	3.51e-06	7.2e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—JUN—hematologic cancer	3.51e-06	7.19e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PTEN—hematologic cancer	3.45e-06	7.08e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CDKN1A—hematologic cancer	3.44e-06	7.06e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PTEN—hematologic cancer	3.44e-06	7.04e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CDKN1A—hematologic cancer	3.43e-06	7.04e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PTEN—hematologic cancer	3.42e-06	7.02e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	3.4e-06	6.97e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PTEN—hematologic cancer	3.39e-06	6.95e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MAPK8—hematologic cancer	3.36e-06	6.89e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.35e-06	6.88e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—AKT1—hematologic cancer	3.35e-06	6.87e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MAPK8—hematologic cancer	3.35e-06	6.87e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—AKT1—hematologic cancer	3.34e-06	6.85e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	3.32e-06	6.8e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	3.31e-06	6.78e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—EP300—hematologic cancer	3.29e-06	6.75e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—EP300—hematologic cancer	3.28e-06	6.72e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—EP300—hematologic cancer	3.27e-06	6.7e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.26e-06	6.68e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.26e-06	6.68e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—EP300—hematologic cancer	3.23e-06	6.63e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—SRC—hematologic cancer	3.19e-06	6.53e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—SRC—hematologic cancer	3.18e-06	6.51e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—SRC—hematologic cancer	3.15e-06	6.45e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—VEGFA—hematologic cancer	3.1e-06	6.36e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—VEGFA—hematologic cancer	3.09e-06	6.34e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PIK3CA—hematologic cancer	3.08e-06	6.32e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—STAT3—hematologic cancer	3.07e-06	6.3e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—NRAS—hematologic cancer	3.07e-06	6.28e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	3.06e-06	6.28e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—STAT3—hematologic cancer	3.06e-06	6.28e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—NRAS—hematologic cancer	3.06e-06	6.26e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—STAT3—hematologic cancer	3.03e-06	6.22e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—NRAS—hematologic cancer	3.03e-06	6.2e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MAPK3—hematologic cancer	2.94e-06	6.02e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MAPK3—hematologic cancer	2.93e-06	6e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	2.9e-06	5.94e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PIK3CA—hematologic cancer	2.89e-06	5.92e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.88e-06	5.9e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MYC—hematologic cancer	2.86e-06	5.85e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TGFB1—hematologic cancer	2.85e-06	5.84e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MYC—hematologic cancer	2.85e-06	5.84e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TGFB1—hematologic cancer	2.84e-06	5.82e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MYC—hematologic cancer	2.82e-06	5.78e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	2.81e-06	5.76e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—KRAS—hematologic cancer	2.64e-06	5.41e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—KRAS—hematologic cancer	2.63e-06	5.39e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—KRAS—hematologic cancer	2.6e-06	5.34e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—AKT1—hematologic cancer	2.52e-06	5.16e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PIK3CA—hematologic cancer	2.43e-06	4.99e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PIK3CA—hematologic cancer	2.42e-06	4.97e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.42e-06	4.96e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PIK3CA—hematologic cancer	2.42e-06	4.95e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	2.39e-06	4.91e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—AKT1—hematologic cancer	2.36e-06	4.84e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TP53—hematologic cancer	2.34e-06	4.81e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TP53—hematologic cancer	2.34e-06	4.79e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TP53—hematologic cancer	2.31e-06	4.75e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—HRAS—hematologic cancer	2.24e-06	4.6e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.24e-06	4.6e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—HRAS—hematologic cancer	2.24e-06	4.58e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—HRAS—hematologic cancer	2.21e-06	4.54e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IL6—hematologic cancer	2.15e-06	4.4e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IL6—hematologic cancer	2.14e-06	4.39e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.13e-06	4.36e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IL6—hematologic cancer	2.12e-06	4.34e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ALB—hematologic cancer	2.1e-06	4.3e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.01e-06	4.12e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—AKT1—hematologic cancer	1.99e-06	4.08e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—AKT1—hematologic cancer	1.98e-06	4.06e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—AKT1—hematologic cancer	1.97e-06	4.05e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—AKT1—hematologic cancer	1.95e-06	4.01e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.85e-06	3.8e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PTEN—hematologic cancer	1.6e-06	3.28e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—EP300—hematologic cancer	1.53e-06	3.13e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.13e-06	2.32e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—AKT1—hematologic cancer	9.23e-07	1.89e-05	CbGpPWpGaD
